Skip to main content
BIOTECH logo

BIOTECH — Investor Relations & Filings

Ticker · BST ISIN · ES0184980003 LEI · 959800GNYT6ZZEWPEW29 BME Growth Professional, scientific and technical activities
Open in API
Filings indexed 2,317 across all filing types
Latest filing 2015-06-05 Net Asset Value
Country ES Spain
Listing BME Growth BST

About BIOTECH

https://asebio.com/en/members/directory…

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Recent filings

Filing Released Lang Actions
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 4, 2015). The content details the estimated un-audited net asset value per share (858.61p) and mentions treasury shares. This directly corresponds to the definition of Net Asset Value updates, which is classified as NAV.
2015-06-05 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 3, 2015). The content details the estimated un-audited net asset value per share (870.47p) and mentions treasury shares. This directly matches the definition for Net Asset Value updates, which is classified as NAV.
2015-06-04 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 2, 2015). The content focuses entirely on reporting the NAV per share and details regarding treasury shares, which directly aligns with the definition of Net Asset Value updates, primarily for investment funds. This matches filing code NAV.
2015-06-03 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (1 June 2015). The content focuses entirely on reporting the NAV per share (881.44p) and mentions treasury shares in relation to NAV dilution. This directly matches the definition for Net Asset Value updates.
2015-06-02 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (May 29, 2015). The content focuses entirely on reporting the NAV per share and mentions treasury shares in relation to NAV. This directly matches the definition for Net Asset Value updates (NAV). The document length is very short, but the content is the actual NAV figure, not an announcement *about* an NAV report, making NAV the most precise classification.
2015-06-01 English
THE BIOTECH GROWTH TRUST PLC - Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly announces the 'Total Voting Rights' as of a specific date (May 31, 2015) and provides the total number of shares in issue and in treasury. It references the Financial Conduct Authority’s Disclosure and Transparency Rules, which govern such notifications. This content directly relates to the official results of shareholder voting rights calculation, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA). It is not an AGM presentation (AGM-R), a full annual report (10-K), or a general earnings release (ER).
2015-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.